<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1922-1254'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment: FISH Analysis for del17p, IGH Breakapart, del13q, t(4;14), and t(14;16) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment: FISH Analysis for del17p, IGH Breakapart, del13q, t(4;14), and t(14;16) </h1>
<div class="post-text">
<p>Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment is an advanced diagnostic test that utilizes Fluorescence In Situ Hybridization (FISH) in combination with CD138 Magnetic Bead Enrichment. This test is used to detect genetic abnormalities such as del17p, IGH breakapart, del13q, t(4;14), and t(14;16) in patients with multiple myeloma. CD138 enrichment enhances the specificity of the test by isolating plasma cells, which are the primary cells involved in multiple myeloma. This test is critical for the diagnosis, risk assessment, and management of treatment strategies for multiple myeloma. </p>
<p>Multiple myeloma is a type of blood cancer characterized by the uncontrolled proliferation of plasma cells in the bone marrow. These plasma cells produce abnormal antibodies that can cause various complications. Genetic abnormalities are common in multiple myeloma and have significant implications regarding the aggressiveness and prognosis of the disease. Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment employs FISH analysis, which uses fluorescent probes to target and visualize specific DNA sequences on chromosomes. The CD138 Magnetic Bead Enrichment process involves isolating plasma cells from the bone marrow sample, enhancing the accuracy of the FISH analysis by concentrating on the relevant cell population. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment: FISH Analysis for del17p, IGH Breakapart, del13q, t(4;14), and t(14;16) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Bone Marrow </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td> No special preparation is required for this test. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>9 Days </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 16000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is CD138 Magnetic Bead Enrichment and why is it used? </h2>
	<p>CD138 is a protein that is highly expressed on the surface of plasma cells. Magnetic Bead Enrichment uses magnetic particles bound to antibodies that recognize CD138, allowing for the separation and concentration of plasma cells from a bone marrow sample. This increases the accuracy and sensitivity of the FISH analysis. </p>
	<h2 class="test-h2 mt-3">How does FISH analysis work? </h2>
	<p>FISH analysis involves using fluorescent probes that bind to specific DNA sequences on chromosomes. Under a fluorescence microscope, these probes emit light, allowing for the visualization and detection of genetic abnormalities such as deletions, translocations, and amplifications. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What is the importance of detecting del17p in multiple myeloma? </h2>
	<p>Del17p refers to the deletion of a part of chromosome 17. This deletion is associated with an aggressive course of multiple myeloma and often indicates resistance to certain therapies. It is considered a high-risk cytogenetic abnormality. </p>
	<h2 class="test-h2 mt-3">What does IGH breakapart indicate? </h2>
	<p>IGH breakapart refers to rearrangements involving the immunoglobulin heavy chain gene located on chromosome 14. These rearrangements are significant because they are often associated with a more aggressive form of multiple myeloma and can influence treatment decisions. </p>
	<h2 class="test-h2 mt-3">Why are del13q, t(4;14), and t(14;16) important to detect? </h2>
	<p>These genetic abnormalities are associated with changes in the behavior of multiple myeloma. For example, t(4;14) and t(14;16) are translocations that are associated with a poorer prognosis, while del13q is a common deletion in multiple myeloma. </p>
	<h2 class="test-h2 mt-3">How will this test affect my treatment plan? </h2>
	<p>The results of this test can help your doctor understand the genetic characteristics of your multiple myeloma. This information is critical for risk stratification and choosing the most appropriate treatment strategy for your condition. </p>
	<h2 class="test-h2 mt-3">Is fasting required for this test? </h2>
	<p>No, fasting is not required for this test. </p>
	<h2 class="test-h2 mt-3">Can this test predict my response to treatment? </h2>
	<p>Yes, certain genetic abnormalities detected by this test, such as del17p, are known to be associated with resistance to specific therapies. This information can be invaluable in guiding treatment decisions. </p>
	<h2 class="test-h2 mt-3">What is the difference between standard cytogenetics and FISH analysis? </h2>
	<p>Standard cytogenetics looks at the overall structure of chromosomes, while FISH analysis is more focused and uses fluorescent probes to look for specific genetic changes. </p>
	<h2 class="test-h2 mt-3"> Is this test painful? </h2>
	<p>The bone marrow aspiration procedure can cause discomfort, but pain medication and local anesthesia are typically used to minimize pain. </p>
	<h2 class="test-h2 mt-3">How should I prepare for the test? </h2>
	<p>No special preparation is needed. However, it is advisable to inform your doctor about any medications you are taking. </p>
	<h2 class="test-h2 mt-3"> Can this test be done on a blood sample instead of bone marrow?</h2>
	<p>Bone marrow is preferred for this test as it provides a more concentrated population of plasma cells, which are the primary cells involved in multiple myeloma. </p>
	<h2 class="test-h2 mt-3">What should I do if my test shows high-risk genetic abnormalities? </h2>
	<p>If the test results indicate high-risk genetic abnormalities, it's important to discuss your treatment options with your doctor, who may suggest more aggressive or novel therapies. </p>
	<h2 class="test-h2 mt-3">How often should this test be done? </h2>
	<p>This test is usually performed at the time of diagnosis. It may be repeated if there is a change in your clinical condition or if your doctor needs updated information to make treatment decisions. </p>
	<h2 class="test-h2 mt-3">What does it mean if no genetic abnormalities are detected? </h2>
	<p>If no genetic abnormalities are detected, it could mean that your multiple myeloma has a more standard risk profile. However, it's important to note that the absence of abnormalities in this test does not rule out the presence of other genetic changes. </p>
	
	<p>By understanding the genetic characteristics of multiple myeloma through Myeloma Cytogenetics-2 with CD138 Magnetic Bead Enrichment, you and your doctor are better equipped to make informed decisions regarding treatment strategies. It is important to discuss the results of this test in detail with your doctor to understand the implications for your specific case. </p>
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>